CAMP4 Therapeutics Corpor... (CAMP)
NASDAQ: CAMP
· Real-Time Price · USD
1.67
0.12 (7.74%)
At close: Aug 15, 2025, 3:59 PM
1.67
0.30%
After-hours: Aug 15, 2025, 04:10 PM EDT
CAMP4 Therapeutics Income Statement
Financials in USD. Fiscal
year is
March - February.
Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 |
Revenue | 858K | 652K | n/a | n/a | n/a | 53.63M | 61.71M | 70.89M | 78.51M | 78.89M | 72.83M | 64.73M | 68.38M | 68.78M | 79.01M | 79.67M | 81.95M | 88.01M | 83.54M | 80.22M |
Cost of Revenue | n/a | n/a | n/a | 9.56M | 9.56M | 36.05M | 39.37M | 43.83M | 50.77M | 52.27M | 43.82M | 39.08M | 40.33M | 40.76M | 45.64M | 47.23M | 47.35M | 53.01M | 52.73M | 49.16M |
Gross Profit | 858K | 234K | n/a | n/a | n/a | 17.57M | 22.34M | 27.06M | 27.74M | 26.61M | 29.01M | 25.65M | 28.05M | 28.02M | 33.37M | 32.45M | 34.6M | 35.01M | 30.81M | 31.05M |
Operating Income | -13.1M | -14.03M | -13.52M | -12.66M | -12.88M | -83.42M | -3.22M | -2.51M | -1.58M | -3.63M | -5.34M | -9.34M | -4.42M | -6.56M | -998K | -1.23M | -289K | -20.01M | -6.25M | -9.91M |
Interest Income | 588K | 610K | 94K | 231K | 395K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -12.43M | -13.28M | -13.48M | -12.58M | -12.45M | -84.97M | -3.79M | -3.98M | -7.58M | -4.46M | -7.37M | -11.92M | -8.93M | -10.34M | -5.09M | -5.71M | -3.48M | -23.36M | -9.21M | -14.18M |
Net Income | -12.43M | -13.28M | -13.48M | -12.58M | -12.45M | -85M | -4.22M | -4.03M | -8.09M | -4.73M | -7.49M | -12.17M | -9.18M | -11.44M | -5.42M | -1.95M | -8.73M | -23.68M | -9.48M | -14.42M |
Selling & General & Admin | 3.81M | 4.69M | 3.81M | 3.27M | 3.13M | 19M | 19.63M | 22.38M | 22.65M | 23.66M | 26.26M | 26.64M | 24.49M | 26.01M | 25.25M | 25.15M | 25.63M | 28.29M | 27.39M | 26.55M |
Research & Development | 10.15M | 10M | 9.7M | 9.56M | 9.74M | 4.05M | 4.8M | 5.84M | 5.33M | 5.48M | 6.76M | 7M | 6.6M | 7.18M | 7.73M | 6.94M | 6.89M | 6.78M | 6.99M | 6.32M |
Other Expenses | n/a | n/a | n/a | -9.56M | -9.56M | -17K | 723K | 1.22M | 1.34M | 1.32M | 1.33M | 1.34M | 1.38M | -98K | -710K | -1.28M | -360K | -52K | 217K | -208K |
Operating Expenses | 13.96M | 14.69M | 13.52M | 12.66M | 3.2M | 24.16M | 25.56M | 29.44M | 29.32M | 30.46M | 34.35M | 34.98M | 32.47M | 34.58M | 34.37M | 33.34M | 33.73M | 36.93M | 36.23M | 34.77M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 1.41M | 1.57M | 1.68M | 1.61M | 1.65M | 1.46M | 1.53M | 3.84M | 3.83M | 3.8M | 3.85M | 3.67M | 3.88M | 3.86M | 4.08M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 8.88M | 9.62M | 11.02M | 10.69M | 12.49M | 12.73M | 11.48M | 10.82M | 13.24M | 12.05M | 12.46M | 12.46M | 14.65M | 13.49M | 12.89M |
Cost & Expenses | 13.96M | 14.69M | 13.52M | 12.66M | 12.88M | 60.22M | 64.93M | 73.27M | 80.08M | 82.73M | 78.17M | 74.06M | 72.8M | 75.34M | 80.01M | 80.57M | 81.08M | 89.93M | 88.95M | 83.93M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 38K | 435K | 52K | 508K | 268K | 126K | 249K | 256K | 205K | 333K | 293K | -264K | 319K | 266K | 240K |
Shares Outstanding (Basic) | 19.51M | 19.51M | 19.51M | 15.81M | 12.12M | 37.43M | 36.99M | 36.63M | 36.13M | 36.36M | 35.69M | 35.72M | 35.55M | 35.14M | 35.15M | 34.84M | 34.68M | 33.98M | 34.26M | 34.02M |
Shares Outstanding (Diluted) | 19.51M | 19.51M | 19.51M | 15.81M | 12.12M | 37.43M | 36.99M | 36.63M | 36.13M | 36.36M | 36.01M | 35.72M | 35.55M | 35.48M | 35.15M | 34.84M | 34.69M | 34.6M | 34.26M | 34.02M |
EPS (Basic) | -0.64 | -0.68 | -0.69 | -0.8 | -1.03 | -2.27 | -0.11 | -0.11 | -0.22 | -0.13 | -0.21 | -0.34 | -0.26 | -0.33 | -0.15 | -0.06 | -0.25 | -0.7 | -0.28 | -0.42 |
EPS (Diluted) | -0.64 | -0.68 | -0.69 | -0.8 | -1.03 | -2.27 | -0.11 | -0.11 | -0.22 | -0.13 | -0.21 | -0.34 | -0.26 | -0.32 | -0.15 | -0.06 | -0.25 | -0.68 | -0.28 | -0.42 |
EBITDA | -12.68M | -13.62M | -13.1M | -12.24M | -12.44M | -1.66M | 3.1M | 3.04M | -387K | 1.58M | -4.52M | -4.78M | -3.4M | -690K | 3.93M | 3.31M | 1.72M | 4.91M | 1.72M | 2.88M |
EBIT | -13.1M | -14.03M | -13.52M | -12.66M | -12.88M | n/a | n/a | -2.51M | -1.58M | -3.63M | -5.34M | -9.34M | -4.42M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Depreciation & Amortization | 421K | 418K | 418K | 424K | 436K | 4.95M | 5.59M | 5.55M | 1.19M | 5.22M | 823K | 4.56M | 1.02M | 5.97M | 5.64M | 5.48M | 1.21M | 6.88M | 6.92M | 6.8M |